Start for free
Start for free
Red Abbey Venture Partners logo

Red Abbey Venture Partners

North America, Maryland, United States, Baltimore

Description

Red Abbey Venture Partners is a life sciences investment firm that was founded in 2004. Since that time, it has invested in 15 privately

Investor Profile

Red Abbey Venture Partners has made 20 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (30%)
  • Series A (25%)
  • Series B (15%)
  • Seed (15%)
  • Series D (10%)
  • Post Ipo Equity (5%)

Country Focus

  • United States (80%)
  • United Kingdom (15%)
  • Canada (5%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics
  • Biopharma
  • Manufacturing
  • Medical Device
  • Mhealth
  • Personal Health
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Red Abbey Venture Partners frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Novartis Venture Fund
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 4
SV Health Investors
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 3
MedImmune Ventures
MedImmune Ventures
North America, Maryland, United States, Gaithersburg
Co-Investments: 4
InterWest Partners
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 4
MPM Capital
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 5
TPG
TPG
North America, California, United States, San Francisco
Co-Investments: 3
Alta Partners
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 5
Bessemer Venture Partners
Bessemer Venture Partners
North America, California, United States, San Francisco
Co-Investments: 5
Wellcome Trust
Wellcome Trust
Europe, England, United Kingdom, London
Co-Investments: 3

Which angels does Red Abbey Venture Partners often collaborate with?

GC
Gary Cohn
North America, New York, United States, New York
Shared Deals: 1
BF
Brad Feld
North America, Colorado, United States, Boulder
Shared Deals: 1
FA
Frank A. Bonsal
North America, Maryland, United States, Baltimore
Shared Deals: 1

What are some of recent deals done by Red Abbey Venture Partners?

Perceiv AI

Montréal, Quebec, Canada

AI-driven precision medicine, forecasting disease progression

AnalyticsArtificial Intelligence (AI)Clinical TrialsHealth CareHealth DiagnosticsMachine LearningMedicalPharmaceuticalPrecision MedicinePredictive Analytics
SeedDec 8, 2022
Amount Raised: $1,500,000
Cohero Health

New York, New York, United States

Cohero Health offers a proprietary connected health platform for those with respiratory illness.

Health CareMedicalMedical DevicemHealthPersonal Health
SeedDec 22, 2015
Amount Raised: $2,000,000
Atopix Therapeutics

Abingdon, Oxfordshire, United Kingdom

Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK

BiotechnologyLife ScienceMedical
Series AOct 8, 2014
Amount Raised: $3,700,000
Corridor Pharmaceuticals

Towson, Maryland, United States

Corridor Pharmaceuticals is a platform-based pulmonary and critical care company developing novel therapeutics for elevated arginase levels.

BiotechnologyHealth CareTherapeutics
Series AJun 24, 2010
Amount Raised: $13,012,475
Oxagen

London, England, United Kingdom

Oxagen is a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series CNov 24, 2009
Amount Raised: $26,700,000
Corridor Pharmaceuticals

Towson, Maryland, United States

Corridor Pharmaceuticals is a platform-based pulmonary and critical care company developing novel therapeutics for elevated arginase levels.

BiotechnologyHealth CareTherapeutics
Series AOct 2, 2009
Amount Raised: $10,750,000
MacroGenics

Rockville, Maryland, United States

MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.

BiotechnologyHealth CareManufacturing
Series DOct 23, 2008
Amount Raised: $25,000,000
Corridor Pharmaceuticals

Towson, Maryland, United States

Corridor Pharmaceuticals is a platform-based pulmonary and critical care company developing novel therapeutics for elevated arginase levels.

BiotechnologyHealth CareTherapeutics
SeedOct 23, 2008
Amount Raised: $2,300,000
Stromedix

Cambridge, Massachusetts, United States

Storemedix is a biomedical company focused on drugs for fibrosis, organ failure and cancer.

BiotechnologyHealth CareMedical Device
Series BApr 21, 2008
Amount Raised: $25,000,000
Advanced BioHealing

Westport, Connecticut, United States

Advanced BioHealing develops regenerative medicine solutions and commercializes cell-based and tissue-engineered products.

BiotechnologyMedicalPharmaceutical
Series CFeb 27, 2007
Amount Raised: $25,500,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator